Ein Update zu PPID beim Pferd

PPID (Pituitary Pars Intermedia Dysfunction) ist die häufigste endokrinologische Erkrankung älterer Pferde. Für die Diagnostik stehen diverse Verfahren zur Verfügung, doch welcher Test erkennt beispielsweise Patienten in einem frühen Krankheitsstadium? Informieren Sie sich über Vor- und Nachteile aktueller Diagnostikmöglichkeiten und Therapieempfehlungen.

• Literatur

• 1 Beech J, Boston R, Lindborg S. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction. J Vet Intern Med 2011; 25: 1431-1438
• 2 Beech J, Boston R, Lindborg S, Russell GE. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia. J Am Vet Med Assoc 2007; 231: 417-426
• 3 Frank N, Andrews F, Durham A, Kritchevsky J, McFarlane D, Schott H. Recommendations for the Diagnosis and Treatment of Pituitary Pars Intermedia Dysfunction (PPID). Revised August 2015, Prepared by the PPID Working Group.
• 4 Frank N, Andrews FM, Sommardahl CS, Eiler H, Rohrbach BW, Donnell RL. Evaluation of the combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses. J Vet Intern Med 2006; 20: 987-993
• 5 Hart KA, Wochele DM, Norton NA, McFarlane D, Woolridge AA, Frank N. Effect of age, season, body condition, and endocrine status on serum free cortisol fraction and insulin concentration in horses. J Vet Intern Med 2016; 30: 653-663
• 6 Ireland JL, McGowan CM. Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors. Vet J 2018; 235: 22-33
• 7 Mastro LM, Adams AA, Urschel KL. Pituitary pars intermedia dysfunction does not necessarily impair insulin sensitivity in old horses. Domest Anim Endocrinol 2015; 50: 14-25
• 8 McFarlane D. Cerebrospinal fluid concentration of hypocretin-1 in horses with equine pituitary pars intermedia disease and its relationship to oxidative stress. J Vet Interm Med 2007; 21: 602
• 9 McFarlane D, Dybdal N, Donaldson MT, Miller L, Cribb AE. Nitration and increased α‐synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J Neuroendocrinol 2005; 17: 73-80
• 10 Van der Kolk JH, Heinrichs M, van Amerongen JD, Stooker RC, in de Wal LJ, van den Ingh TS. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma. Am J Vet Res 2004; 65: 1701-1707